Bachem Holding AG/Fr. BANB
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Bachem Holding AG
Bachem Holding AG is a Swiss company specializing in the biotechnology and pharmaceutical industries. It focuses on the development and production of peptides and oligonucleotides for the pharmaceutical and biotech sectors. Its offerings include active pharmaceutical ingredients (APIs) and customized synthesis services. Founded in 1971, Bachem's headquarters is located in Bubendorf, Switzerland, with additional facilities in the United States, Europe, and Asia. The company is known for its extensive expertise in peptide chemistry and its strategic focus on innovation and quality in manufacturing, contributing to its competitive position in the global pharmaceuticals market.
Ticker
Fr. BANB
Sector
Primary listing
XSWX
Employees
2,363
Headquarters
Bubendorf, Switzerland
Website
BANB Metrics
BasicAdvanced
CHF 4.9bn
33.07
CHF 1.98
0.78
CHF 0.90
0.69%
Price and volume
Market cap
CHF 4.9bn
Beta
0.78
52-week high
CHF 83.25
52-week low
CHF 48.52
Average daily volume
153k
Dividend rate
CHF 0.90
Financial strength
Current ratio
1.792
Quick ratio
0.541
Long term debt to equity
0.005
Total debt to equity
4.133
Dividend payout ratio (TTM)
20.65%
Interest coverage (TTM)
420.36%
Profitability
EBITDA (TTM)
210.756
Gross margin (TTM)
28.74%
Net profit margin (TTM)
21.41%
Operating margin (TTM)
24.07%
Effective tax rate (TTM)
4.86%
Revenue per employee (TTM)
CHF 290,000
Management effectiveness
Return on assets (TTM)
5.19%
Return on equity (TTM)
10.44%
Valuation
Price to earnings (TTM)
33.074
Price to revenue (TTM)
7.08
Price to book
3.39
Price to tangible book (TTM)
3.46
Price to free cash flow (TTM)
-85.109
Free cash flow yield (TTM)
-1.17%
Free cash flow per share (TTM)
-0.771
Dividend yield (TTM)
1.37%
Forward dividend yield
0.69%
Growth
Revenue change (TTM)
14.84%
Earnings per share change (TTM)
23.77%
3-year revenue growth (CAGR)
9.34%
10-year revenue growth (CAGR)
12.79%
3-year earnings per share growth (CAGR)
13.28%
10-year earnings per share growth (CAGR)
15.50%
3-year dividend per share growth (CAGR)
6.27%
10-year dividend per share growth (CAGR)
7.18%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs